Intravenous administration of human umbilical cord blood-mononuclear cells dose-dependently relieve neurologic deficits in rat intracerebral hemorrhage model

Annals of Anatomy

Volumn 195, Issue 1, 2013, Pages 39-49

  Seghatoleslam, Masoumeh ^a   Jalali, Mehdi ^a   Nikravesh, Mohammad Reza ^a   Hamidi Alamdari, Daryoush ^a   Hosseini, Mahmoud ^a   Fazel, Alireza ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cell transplantation; Functional recovery; Human umbilical cord blood mononuclear cells (HUC MCs); Intracerebral hemorrhage (ICH)

Indexed keywords

BROXURIDINE; CD34 ANTIGEN; CD45 ANTIGEN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN SIZE; CELL LABELING; CELL MIGRATION; CELL TRANSPLANTATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRAVENOUS ADMINISTRATION; MALE; MONONUCLEAR CELL; NONHUMAN; RAT; TREATMENT OUTCOME; UMBILICAL CORD BLOOD MONONUCLEAR CELL;

ANIMALS; ANTIGENS, CD45; ANTIMETABOLITES; BEHAVIOR, ANIMAL; BRAIN; BROMODEOXYURIDINE; CELL MOVEMENT; CELL SEPARATION; CELL SURVIVAL; CENTRIFUGATION, DENSITY GRADIENT; CORD BLOOD STEM CELL TRANSPLANTATION; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACRANIAL HEMORRHAGES; MALE; MONOCYTES; NERVOUS SYSTEM DISEASES; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; STROKE;

ANIMALIA; BACTERIA (MICROORGANISMS); RATTUS;

EID: 84873094541     PISSN: 09409602     EISSN: 16180402     Source Type: Journal    
DOI: 10.1016/j.aanat.2012.05.002     Document Type: Article

References (70)

1. Barone F.C., Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 1999, 19(8):819-834. 10.1097/00004647-199908000-00001.
2. Bliss T., Guzman R., Daadi M., Steinberg G.K. Cell transplantation therapy for stroke. Stroke 2007, 38(2 Suppl.):817-826. 10.1161/01.STR.0000247888.25985.62.
3. Bogousslavsky J., Van Melle G., Regli F. The lausanne stroke registry. Stroke 1988, 19:1083. 10.1161/01.STR.19.9.1083.
4. Borlongan C.V., Hadman M., Sanberg C.D., Sanberg P.R. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004, 35:2385-2389. 10.1161/01.STR.0000141680.49960.d7.
5. Bracci-Laudiero L., Celestino D., Starace G., Antonelli A., Lambiase A., Procoli A., Rumi C., Lai M., Picardi A., Ballatore G., Bonini S., Aloe L. CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA. J. Neuroimmunol. 2003, 136:130-139. 10.1016/S0165-5728(03)00007-9.
6. Broderick J.P., Adams H.P., Barsan W., Feinberg W., Feldmann E., Grotta J., Kase C., Krieger D., Mayberg M., Tilley B., Zabramski J.M., Zuccarello M. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999, 30:905-915. 10.1161/01.STR.30.4.905.
7. Broxmeyer H.E., Douglas G.W., Hangoc G., Cooper S., Bard J., English D., Arny M., Thomas L., Boyse E.A. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:3828-3832. 10.1002/stem.5530080708.
8. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., Sanchez-Ramos J., Chopp M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001, 32(11):2682-2688. 10.1161/hs1101.098367.
9. Chen J., Li Y., Katakowski M., Chen X., Wang L., Lu D., Lu M., Gautam S.C., Chopp M. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J. Neurosci. Res. 2001, 73(6):778-786. 10.1002/jnr.10691.
10. Chen J., Li Y., Zhang R., Katakowski M., Gautam S.C., Xu Y., Lu M., Zhang Z., Chopp M. Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res. 2004, 1005(1-2):21-28. 10.1016/j.brainres.2003.11.080.
11. Chouthai N.S., Sampers J., Desai N., Smith G.M. Changes in neurotrophin levels in umbilical cord blood from infants with different gestational ages and clinical conditions. Pediatr. Res. 2003, 53:965-969. 10.1203/01.PDR.0000061588.39652.26.
12. de Paula S., Vitola A.S., Greggio S., de Paula D., Mello P.B., Lubianca J.M., Xavier L.L., Fiori H.H., Dacosta J.C. Hemispheric brain injury and behavioral deficits induced by severe neonatal hypoxia-ischemia in rats are not attenuated by intravenous administration of human umbilical cord blood cells. Pediatr. Res. 2009, 65(6):631-635. 10.1203/PDR.0b013e31819ed5c8.
13. De Ryck M., Van Reempts J., Borgers M., Wauquier A., Janssen P.A. Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke 1989, 20:1383-1390. 10.1161/01.STR.20.10.1383.
14. Del Bigio M.R., Yan H.J., Buist R., Peeling J. Experimental intracerebral hemorrhage in rats: magnetic resonance imaging and histopathological correlates. Stroke 1996, 27:2312-2319. 10.1161/01.STR.27.12.2312.
15. Erices A., Conget P., Minguell J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 2000, 109:235-242. 10.1046/j.1365-2141.2000.01986.x.
16. Foulkes M.A., Wolf P.A., Price T.R., Mohr J.P., Hier D.B. The Stroke Data Bank: design methods and baseline characteristics. Stroke 1988, 19:547-554. 10.1161/01.STR.19.5.547.
17. Gong C., Hoff J.T., Kee R.F. Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res. 2000, 871(1):57-65. 10.1016/S0006-8993(00)2427-6.
18. Harris D.T. Cord blood stem cells: a review of potential neurological applications. Stem Cell Rev. 2008, 4:269-274. 10.1007/s12015-008-9039.
19. Hassanein S.M., Amer H.A., Shahab A.A., Hellal M.M. Umbilical cord blood CD45 (+) CD34 (+) cells co-expression in preterm and full-term neonates: a pilot study. J. Matern. Fetal Neonatal Med. 2011, 24(2):229-233. 10.3109/14767058.2010.482606.
20. Hemphill J.C., Bonovich D.C., Besmertis L., Manley G.T., Johnston S.C. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001, 32(4):891-897. 10.1161/01.STR.32.4.891.
21. Hua Y., Schallert T., Keep R.F., Wu J., Hoff J.T., Xi G. Behavioral tests after intracerebral hemorrhage in the rat. Stroke 2002, 33:2478-2484. 10.1161/01. STR.0000032302.91894.0F.
22. Jeong S.W., Chu K., Jung K.H., Kim S.U., Kim M., Roh J.K. Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 2003, 34:2258-2263. 10.1161/01.STR.0000083698.20199.1.
23. Kawasaki-Oyama R.S., Braile D.M., Caldas H.S., Leal J.C.F., Goloni-Bertollo E.M., Pavarino-Bertelli E.C., Abbud Filho M., Santos I.D. Blood mesenchymal stem cell culture from the umbilical cord with and without Ficoll-Paque density gradient method. Rev. Bras. Cir. Cardiovasc. 2008, 23(1):29-34. 10.1590/S0102-76382008000100006.
24. Kim J.M., Lee S.T., Chu K., Jung K.H., Song E.C., Kim S.J., Sinn D.I., Kim J.H., Park D.K., Kang K.M., Hyung Hong N., Park H.K., Won C.H., Kim K.H., Kim M., Kun Lee S., Roh J.K. Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res. 2007, 1183:43-50. 10.1016/j.brainres.2007.09.005.
25. Lapchak P.A. Hemorrhagic transformation following ischemic stroke: significance, causes and relationship to therapy and treatment. Curr. Neurol. Neurosci. Rep. 2002, 2:38-43. 10.1007/s11910-002-0051-0.
26. Larsson L.C., Frielingsdorf H., Mirza B., Hansson S.J., Anderson P., Czech M., Strandberg K.A., Widner H. Porcine neural xenograft in rats and mice: donor tissue development and characteristics of rejection. Dev. Neurol. 2001, 172:100-114. 10.1006/exnr.2001.7738.
27. Lee S.T., Chu K., Sinn D.I., Jung K.H., Kim E.H., Kim S.J., Kim J.M., Ko S.Y., Kim M., Roh J.K. Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage. J. Neurochem. 2006, 96:728-1739. 10.1111/j.1471-4159.2006.03697.x.
28. Lee H.J., Kim K.S., Kim E.J., Choi H.B., Lee K.H., Park I.H., Ko Y., Jeong S.W., Kim S.U. Brain transplantation of immortalized human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model. Stem Cells 2007, 25(5):1204-1212. 10.1634/stemcells.2006-0409.
29. Lequeux C., Oni G., Mojallal A., Damour O., Brown S.A. Adipose derived stem cells: efficiency, toxicity, stability of BrdU labeling and effects on self-renewal and adipose differentiation. Mol. Cell. Biochem. 2011, 351(1-2):65-75. 10.1007/s11010-011-0712-x.
30. Li Y., Chen J., Chen X.G., Wang L., Gautam S.C., Xu Y.X., Katakowski M., Zhang L.J., Lu M., Janakiraman N., Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002, 59:514-523. Available in: http://www.ncbi.nlm.nih.gov/pubmed/12196642.
31. Liao Y., Geyer M.B., Yang A.J., Cairo M.S. Cord blood transplantation and stem cell regenerative potential. Exp. Hematol. 2011, 39(4):393-412. 10.1016/j.exphem.2011.01.002.
32. Liao W., Zhong J., Yu J., Xie J., Liu Y., Du L., Yang S., Liu P., Xu J., Wang J., Han Z., Han Z.C. Therapeutic benefit of human umbilical cord derived mesenchymal stromal cells in intracerebral hemorrhage rat: implications of anti-inflammation and angiogenesis. Cell. Physiol. Biochem. 2009, 24(3-4):307-316. 10.1159/000233255.
33. Liu H.Y., Zhang Q.J., Li H.J., Han Z.C. Effect of intracranial transplantation of CD34+ cells derived from human umbilical cord blood in rats with cerebral ischemia. Chin. Med. J. 2006, 119(20):1744-1748.
34. Liu A.M., Lu G., Tsang K.S., Li G., Wu Y., Huang Z.S., Ng H.K., Kung H.F., Poon W.S. Umbilical cord-derived mesenchymal stem cells with forced expression of hepatocyte growth factor enhance remyelination and functional recovery in a rat intracerebral hemorrhage model. Neurosurgery 2010, 67(2):357-365. 10.1227/01.NEU.0000371983.06278.B3.
35. Madlambayan G., Rogers I. Umbilical cord-derived stem cells for tissue therapy: current and future uses. Regen. Med. 2006, 1(6):777-787. 10.2217/17460751.1.6.777.
36. Mahmood A., Lu D., Wang L., Chopp M. Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury. J. Neurotrauma 2002, 19(12):1609-1617. 10.1089/089771502762300265.
37. Mahmood A., Lu D., Lu M., Chopp M. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 2003, 53(3):697-702. 10.1227/01.NEU.0000079333.61863.AA.
38. Makinen S., Kekarainen T., Nystedt J., Liimatainen T., Huhtala T., Narvanen A., Laine J., Jolkkonen J. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Res. 2006, 1123(1):207-215. 10.1016/j.brainres.2006.09.056.
39. Meier C., Middelanis J., Wasielewski B., Neuhoff S., Roth-Haerer A., Gantert M., Dinse H.R., Dermietzel R., Jensen A. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr. Res. 2006, 59(2):244-249. 10.1203/01.pdr.0000197309.08852.f5.
40. Mohr J.P., Caplan L.R., Melski J.W., Goldstein R.J., Duncan G.W., Kistler J.P., Pessin M.S., Bleich H.L. The Harvard cooperative stroke registry: a prospective registry. Neurology 1978, 28:754-762. Available in: http://www.neurology.org/content/28/8/754.abstract.
41. Murohara T., Ikeda H., Duan J., Shintani S., Sasaki K., Eguchi H., Onitsuka I., Matsui K., Imaizumi T. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 2000, 105:1527-1536. 10.1172/JCI8296.
42. Nan Z., Grande A., Sanberg C.D., Sanberg P.R., Low W.C. Infusion of human umbilical cord blood ameliorates neurologic deficits in rats with hemorrhagic brain injury. Ann. N. Y. Acad. Sci. 2005, 1049:84-96. 10.1196/annals.1334.009.
43. Newcomb J.D., Ajmo C.T., Sanberg C.D., Sanberg P.R., Pennypacker K.R., Willing A.E. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 2006, 15(3):213-223.
44. Newman M., Willing A., Cassady C.J., Manresa J.J., Kedziorek D.A., Davis C. In vitro migration and phenotype identification of human umbilical cord blood (HUCB) cells to stroke brain. Exp. Neurol. 2003, 181:84-112. 10.1016/S0014-4886(03)00063-3.
45. Nonaka M., Yoshikawa M., Nishimura F., Yokota H., Kimura H., Hirabayashi H., Nakase H., Ishizaka S., Wanaka A., Sakaki T. Intraventricular transplantation of embryonic stem cell-derived neural stem cells in intracerebral hemorrhage rats. Neurol. Res. 2004, 26(3):265-267. 10.1179/016164104225014049.
46. Pan Y., Nastav J.B., Zhang H., Bretton R.H., Panneton W.M., Bicknese A.R. Engraftment of freshly isolated or cultured human umbilical cord blood cells and the effect of cyclosporin A on the outcome. Exp. Neurol. 2005, 192:365-372. 10.1016/j.expneurol.2004.11.011.
47. Park D.H., Borlongan C.V., Willing A.E., Eve D.J., Cruz L.E., Sanberg C.D., Chung Y.G., Sanberg P.R. Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant. 2009, 18:985-998. 10.3727/096368909X471279.
48. Pesce M., Orlandi A., Iachininoto M.G., Straino S., Torella A.R., Rizzuti V., Pompilo G., Bonanno G., Scambia G., Capogrossi M.C. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ. Res. 2003, 93(5):e51-e62. 10.1161/01.RES.0000090624.04507.45.
49. Pimentel-Coelho P.M., Magalhães E.S., Lopes L.M., deAzevedo L.C., Santiago M.F., Menez-Otero R. Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum. Stem Cells Dev. 2010, 19(3):351-358. 10.1089/scd.2009.0049.
50. Pomyje J., Zivny J., Sefc L., Plasilova M., Pytlik R., Necas E. Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34/CD133 cells. Eur. J. Haematol. 2003, 70:143-150. 10.1034/j.1600-0609.2003.00040.x.
51. Qureshi A.I., Tuhrim S., Broderick J.P., Batjer H.H., Hondo H., Hanley D.F. Spontaneous intracerebral hemorrhage. N. Engl. J. Med. 2001, 344:1450-1460. 10.1055/s-0030-1268865.
52. Rainsford E., Reen D.J. Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br. J. Haematol. 2002, 116:702-709. 10.1046/j.0007-1048.2001.03321.x.
53. Ribo M., Grotta J.C. Latest advances in intracerebral hemorrhage. Curr. Neurol. Neurosci. Rep. 2006, 6:17-22. 10.1007/s11910-996-0004-0.
54. Riegelsberger U.M., Deten A., Pösel C., Zille M., Kranz A., Boltze J., Wagner D.C. Intravenous human umbilical cord blood transplantation for stroke: impact on infarct volume and caspase-3-dependent cell death in spontaneously hypertensive rats. Exp. Neurol. 2011, 227(1):218-223. 10.1016/j.expneurol.2010.11.008.
55. Riordan N.H., Chan K., Marleau A.M., Ichim T.E. Cord blood in regenerative medicine: do we need immune suppression?. J. Transl. Med. 2007, 5:8. 10.1186/1479-5876-5-8.
56. Rosenberg G.A., Navratil M. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 1997, 48(4):921-926.
57. Sanberg P.R., Willing A.E., Garbuzova-Davis S., Saporta S., Liu G., Sanberg C.D., Bickford P.C., Klasko S.K., El-Badri N.S. Umbilical cord blood-derived stem cells and brain repair. Ann. N. Y. Acad. Sci. 2005, 1049:67-83. 10.1196/annals.1334.008.
58. Schouten J.W., Fulp C.T., Royo N.C., Saatman K.E., Watson D.J., Snyder E.Y., Trojanowski J.Q., Prockop D.J., Maas A.I., McIntosh T.K. A review and rationale for the use of cellular transplantation as a therapeutic strategy for traumatic brain injury. J. Neurotrauma 2004, 21:1501-1538. 10.1089/neu.2004.21.1501.
59. Seyfried D., Ding J., Han Y., Li Y., Chen J., Chopp M. Effects of intravenous administration of human bone marrow stromal cells after intracerebral hemorrhage in rats. J. Neurosurg. 2006, 104(2):313-318. Available in: http://www.ncbi.nlm.nih.gov/pubmed/16509507.
60. Sherrard R.M., Bower A.J. BDNF and NT3 extend the critical period for developmental climbing fiber plasticity. Neuroreport 2001, 12:2871-2874. doi:00001756-200109170-00023.
61. Sirchia G., Rebulla P. Placental/umbilical cord blood transplantation. Haematologica 1999, 84(8):738-747. Available in: http://www.ncbi.nlm.nih.gov/pubmed/18341392.
62. Taguchi A., Soma T., Tanaka H., Kanda T., Nishimura H., Yoshikawa H., Tsukamoto Y., Iso H., Fujimori Y., Stern D.M., Naritomi H., Matsuyama T. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 2004, 114(3):330-338. 10.1172/JCI20622.
63. Vendrame M., Cassady J., Newcomb J., Butler T., Pennypacker K.R., Zigova T., Sanberg C.D., Sanberg P.R., Willing A.E. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 2004, 35(10):2390-2395. 10.1161/01.STR.0000141681.06735.9b.
64. Vendrame M., Gemma C., de Mesquita D., Collier L., Bickford P.C., Sanberg C.D., Sanberg P.R., Pennypacker K.R., Willing A.E. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 2005, 14:595-604. 10.1089/scd.2005.14.595.
65. Walker P., Tarris R.H., Weichsel M.E., Scott S.M., Fisher D.A. Nerve growth factor in human umbilical cord serum: demonstration of a veno-arterial gradient. J. Clin. Endocrinol. Metab. 1981, 53:218-220.
66. Willing A.E., Lixian J., Milliken M., Poulos S., Zigova T., Song S., Hart C., Sanchez-Ramos J., Sanberg P.R. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci. Res. 2003, 73(3):296-307. 10.1002/jnr.10659.
67. Yasuhara T., Hara K., Maki M., Xu L., Yu G., Ali M.M., Masuda T., Yu S.J., Bae E.K., Hayashi T., Matsukawa N., Kaneko Y., Kuzmin-Nichols N., Ellovitch S., Cruz E.L., Klasko S.K., Sanberg C.D., Sanberg P.R., Borlongan C.V. Mannitol facilitates neurotrophic factor upregulation and behavioral recovery in neonatal hypoxic-ischemic rats with human umbilical cord blood grafts. J. Cell. Mol. Med. 2010, 14(4):914-921. 10.1111/j.1582-4934.2008.00671.x.
68. Zawadzka M., Lukasiuk K., Machaj E.K., Pojda Z., Kaminska B. Lack of migration and neurological benefits after infusion of umbilical cord blood cells in ischemic brain injury. Acta Neurobiol. Exp. 2009, 69(1):46-51. Available in: http://psjc.icm.edu.pl/psjc/cgi-bin/getdoc.cgi?AAAA024216 and http://www.ane.pl/pdf/6905.pdf.
69. Zhang H., Huang Z., Xu Y., Zhang S. Differentiation and neurological benefit of the mesenchymal stem cells transplanted into the rat brain following intracerebral hemorrhage. Neurol. Res. 2006, 28(1):104-112. 10.1179/016164106X91960.
70. Zhang L., Schallert T., Zhang Z.G., Jiang Q., Arniego P., Li Q., Li Q., Lu M., Chopp M. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J. Neurosci. Methods 2002, 117(2.):207-214. 10.1016/S0165-0270(02)00114-0.